Literature DB >> 34105102

Evaluation of liver function in patients with chronic hepatitis B using Gd-EOB-DTPA-enhanced T1 mapping at different acquisition time points: a feasibility study.

Jiamin Li1, Boling Cao1, Xinjun Bi2, Weipeng Chen1, Lanjing Wang1, Zhongli Du1, Xueqin Zhang3, Xiangrong Yu4.   

Abstract

PURPOSE: This study aimed to explore the impact of different acquisition times on the evaluation of liver function levels in chronic hepatitis B using Gd-EOB-DTPA-enhanced T1 positioning technology under 3.0 Tesla magnetic resonance imaging (MRI).
METHODS: A total of 146 patients with chronic hepatitis B (CHB) were classified into four groups as follows: chronic hepatitis B without liver cirrhosis (CH, 22 cases), liver cirrhosis with Child-Pugh classification A (LCA 63 cases), Child-Pugh B (LCB 47 cases) and Child-Pugh C (LCC 14 cases). Normal liver function (NLF) group was composed of 23 persons who had healthy liver and no medical histories of hepatitis. T1 mapping images were performed before and after administration of Gd-EOB-DPTA using Look-Locker sequence. Changes in T1 relaxation time (T1rt), the reduction rate of T1 relaxation time (ΔT1) and the increase in T1 relaxation rate (ΔR1) of liver over time (at 5, 10, 15 and 20 min) were investigated and compared among all five groups using a one-way analysis of variance (ANOVA). The Spearman's rank correlation coefficient (r) was used to show the correlations of these parameters in different liver function groups.
RESULTS: In the NLF, CH, LCA and LCB groups, postT1 gradually decreased, while the ΔT1 and ΔR1 gradually increased with time. The parameters were compared between different liver function levels at the same time point, and the differences were statistically significant except for NLF-CH, NLF-LCA and CH-LCA. There was no significant difference in the area under the ROC curve of other parameters at 10, 15 and 20 min. At each time point, no correlation was found between preT1rt and the degrees of liver function. PostT1rt was positively correlated with liver function classification, while ΔT1 and ΔR1 were negatively correlated with liver function classification.
CONCLUSION: Gd-EOB-DTPA-enhanced T1 mapping magnetic resonance imaging is beneficial to assess liver function. Using the Gd-EOB-DTPA to enhance T1 mapping imaging to assess liver function can shorten the observation time of the hepatobiliary period and 10 min after enhancement may be the best time point.

Entities:  

Keywords:  Liver diseases; Liver function tests; Magnetic resonance imaging; T1-mapping

Year:  2021        PMID: 34105102     DOI: 10.1007/s11547-021-01382-4

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  17 in total

1.  Evaluation of MR imaging with T1 and T2* mapping for the determination of hepatic iron overload.

Authors:  B Henninger; C Kremser; S Rauch; R Eder; H Zoller; A Finkenstedt; H J Michaely; M Schocke
Journal:  Eur Radiol       Date:  2012-05-30       Impact factor: 5.315

2.  Visualization of liver uptake function using the uptake contrast-enhanced ratio in hepatobiliary phase imaging.

Authors:  Shigeru Matsushima; Yozo Sato; Hidekazu Yamaura; Mina Kato; Yasutomi Kinosada; Seiichi Era; Kazuya Takahashi; Yoshitaka Inaba
Journal:  Magn Reson Imaging       Date:  2014-02-18       Impact factor: 2.546

3.  Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging.

Authors:  Akira Yamada; Takeshi Hara; Feng Li; Yasunari Fujinaga; Kazuhiko Ueda; Masumi Kadoya; Kunio Doi
Journal:  Radiology       Date:  2011-06-28       Impact factor: 11.105

Review 4.  Update on epidemiology of hepatitis B and C in China.

Authors:  Yan Cui; Jidong Jia
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

5.  3D T1 relaxometry pre and post gadoxetic acid injection for the assessment of liver cirrhosis and liver function.

Authors:  Cecilia Besa; Octavia Bane; Guido Jajamovich; Joseph Marchione; Bachir Taouli
Journal:  Magn Reson Imaging       Date:  2015-06-26       Impact factor: 2.546

6.  Liver fibrosis staging using T1 mapping on gadoxetic acid-enhanced MRI compared with DW imaging.

Authors:  Y Ding; S-X Rao; T Zhu; C-Z Chen; R-C Li; M-S Zeng
Journal:  Clin Radiol       Date:  2015-07-09       Impact factor: 2.350

Review 7.  Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions.

Authors:  Ahmed Ba-Ssalamah; Martin Uffmann; Sanjai Saini; Nina Bastati; Christian Herold; Wolfgang Schima
Journal:  Eur Radiol       Date:  2008-09-23       Impact factor: 5.315

8.  Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease.

Authors:  Ying Ding; Sheng-Xiang Rao; Tao Meng; Caizhong Chen; Renchen Li; Meng-Su Zeng
Journal:  Eur Radiol       Date:  2014-01-26       Impact factor: 5.315

9.  Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart.

Authors:  Daniel R Messroghli; Aleksandra Radjenovic; Sebastian Kozerke; David M Higgins; Mohan U Sivananthan; John P Ridgway
Journal:  Magn Reson Med       Date:  2004-07       Impact factor: 4.668

10.  Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI.

Authors:  Michael Haimerl; Niklas Verloh; Florian Zeman; Claudia Fellner; René Müller-Wille; Andreas G Schreyer; Christian Stroszczynski; Philipp Wiggermann
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

View more
  5 in total

Review 1.  Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions.

Authors:  Matteo Renzulli; Nicolò Brandi; Giulia Argalia; Stefano Brocchi; Andrea Farolfi; Stefano Fanti; Rita Golfieri
Journal:  Radiol Med       Date:  2022-01-13       Impact factor: 3.469

Review 2.  Management of cutaneous melanoma: radiologists challenging and risk assessment.

Authors:  Vincenza Granata; Igino Simonetti; Roberta Fusco; Sergio Venanzio Setola; Francesco Izzo; Luigi Scarpato; Vito Vanella; Lucia Festino; Ester Simeone; Paolo Antonio Ascierto; Antonella Petrillo
Journal:  Radiol Med       Date:  2022-07-14       Impact factor: 6.313

Review 3.  Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect.

Authors:  Vincenza Granata; Roberta Fusco; Federica De Muzio; Carmen Cutolo; Sergio Venanzio Setola; Igino Simonetti; Federica Dell'Aversana; Francesca Grassi; Federico Bruno; Andrea Belli; Renato Patrone; Vincenzo Pilone; Antonella Petrillo; Francesco Izzo
Journal:  J Clin Med       Date:  2022-05-13       Impact factor: 4.964

Review 4.  Complications after Thermal Ablation of Hepatocellular Carcinoma and Liver Metastases: Imaging Findings.

Authors:  Federica De Muzio; Carmen Cutolo; Federica Dell'Aversana; Francesca Grassi; Ludovica Ravo; Marilina Ferrante; Ginevra Danti; Federica Flammia; Igino Simonetti; Pierpaolo Palumbo; Federico Bruno; Luca Pierpaoli; Roberta Fusco; Andrea Giovagnoni; Vittorio Miele; Antonio Barile; Vincenza Granata
Journal:  Diagnostics (Basel)       Date:  2022-05-05

Review 5.  Structured Reporting in Radiological Settings: Pitfalls and Perspectives.

Authors:  Vincenza Granata; Federica De Muzio; Carmen Cutolo; Federica Dell'Aversana; Francesca Grassi; Roberta Grassi; Igino Simonetti; Federico Bruno; Pierpaolo Palumbo; Giuditta Chiti; Ginevra Danti; Roberta Fusco
Journal:  J Pers Med       Date:  2022-08-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.